A 39-year-old cisgender woman with HIV presents to the emergency room with a diffuse erythematous rash. She restarted antiretroviral therapy 2 weeks ago with a regimen consisting of darunavir-cobicistat-tenofovir alafenamide-emtricitabine, doravirine, and fostemsavir. She has a prior history of developing a diffuse erythematous rash when taking trimethoprim-sulfamethoxazole. She has no other symptoms and is afebrile. Additional laboratory studies show normal hepatic aminotransferase levels and no evidence of eosinophilia.
Which one of the following is the most likely cause of the patient's rash?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 21st, 2023
September 21st, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5